Formoterol - PDFSEARCH.IO - Document Search Engine

Formoterol
Results: 306

#	Item
241	Whose Responsibility is Digital Inclusion? London, 11th April 2005 Evidence from the 2005 Oxford Internet Survey Add to Reading List Source URL: www.oii.ox.ac.uk Language: English World Internet Project WIP Formoterol Balliol College Oxford Internet in the United Kingdom Oxford Internet Institute
242	The Internet in Britain: The Oxford Internet Survey (OxIS[removed]Speakers: •William H. Dutton, Director, Oxford Internet Institute (OII) •Helen Margetts, Professor of Society and the Internet, OII Add to Reading List Source URL: www.oii.ox.ac.uk Language: English Internet Formoterol Technology Electronics Numbers Broadband Internet access Rights
243	Internet Generations Bill Dutton Oxford Internet Institute (OII) University of Oxford www.ox.ac.uk Presentation for an OII workshop on the Oxford Internet Surveys (OxIS), Add to Reading List Source URL: www.oii.ox.ac.uk Language: English Internet in the United Kingdom Oxford Internet Institute Internet Formoterol Quartile Technology Electronics Digital media Broadband Balliol College Oxford
244	FDA Presentation Advair Diskus[removed] Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:16 Combination drugs GlaxoSmithKline Asthma Chronic lower respiratory diseases Fluticasone/salmeterol Salmeterol Formoterol Budesonide/formoterol Long-acting beta-adrenoceptor agonist Pulmonology Medicine Respiratory therapy
245	Microsoft PowerPoint[removed]Core Slides (CI) Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:24 Budesonide/formoterol Asthma Formoterol Chronic lower respiratory diseases Budesonide Long-acting beta-adrenoceptor agonist AstraZeneca Pulmonology Medicine Respiratory therapy
246	Regulatory Perspectives on clinical Trials Endpoints Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:21 Phenethylamines Asthma Phenols Amphetamines Salmeterol Formoterol Long-acting beta-adrenoceptor agonist Bronchodilator Omalizumab Pulmonology Medicine Respiratory therapy
247	Microsoft PowerPoint[removed]Introduction (CI) Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:24 Medicine Phenethylamines Chronic lower respiratory diseases Asthma Amphetamines Formoterol Long-acting beta-adrenoceptor agonist Salmeterol Beta2-adrenergic agonist Pulmonology Phenols Respiratory therapy
248	Foradil® (formoterol fumarate inhalation powder) FDA Advisory Committee Meeting on the safety of longacting beta2-agonists for the treatment of asthma in adults and children (December 10-11, [removed]BRIEFING DOCUMENT Add to Reading List Source URL: www.fda.gov Language: English - Date: 2008-12-05 08:30:04 Phenols Chronic lower respiratory diseases Phenethylamines Asthma Formoterol Salmeterol Chronic obstructive pulmonary disease Salbutamol Placebo Medicine Pulmonology Respiratory therapy
249	Discussion of benefits in the context of risks of LABAs for the treatment of asthma Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:20 Combination drugs Asthma Phenethylamines Salmeterol Phenols GlaxoSmithKline Fluticasone/salmeterol Formoterol Budesonide/formoterol Medicine Pulmonology Respiratory therapy
250	Regulatory Perspectives on clinical Trials Endpoints Add to Reading List Source URL: www.fda.gov Language: English - Date: 2009-01-05 11:05:26 Phenethylamines Phenols Asthma Salmeterol Chronic lower respiratory diseases Formoterol Long-acting beta-adrenoceptor agonist Bronchodilator Omalizumab Pulmonology Medicine Respiratory therapy

UPDATE